{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T15:54:19Z","timestamp":1789833259972,"version":"4.0.1"},"reference-count":92,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"vor","delay-in-days":1461,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["kidney-international.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Kidney International"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1016\/j.kint.2015.12.003","type":"journal-article","created":{"date-parts":[[2016,1,22]],"date-time":"2016-01-22T05:21:41Z","timestamp":1453440101000},"page":"278-288","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":82,"title":["Diagnosis of complement alternative pathway disorders"],"prefix":"10.1016","volume":"89","author":[{"given":"Andrea","family":"Angioi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando C.","family":"Fervenza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjeev","family":"Sethi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuzhou","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard J.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Murray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens","family":"Van Praet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonello","family":"Pani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"An S.","family":"De Vriese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.kint.2015.12.003_bib1","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/ki.2012.313","article-title":"Circulating complement activation in patients with anti-neutrophil cytoplasmic antibody-associated vasculitis","volume":"83","author":"Gou","year":"2013","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2015.12.003_bib2","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.semnephrol.2013.08.001","article-title":"Overview of complement activation and regulation","volume":"33","author":"Noris","year":"2013","journal-title":"Semin Nephrol"},{"key":"10.1016\/j.kint.2015.12.003_bib3","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.4049\/jimmunol.176.3.1305","article-title":"The central role of the alternative complement pathway in human disease","volume":"176","author":"Thurman","year":"2006","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.kint.2015.12.003_bib4","doi-asserted-by":"crossref","first-page":"2774","DOI":"10.1016\/j.molimm.2009.04.029","article-title":"Complement in human diseases: lessons from complement deficiencies","volume":"46","author":"Botto","year":"2009","journal-title":"Mol Immunol"},{"key":"10.1016\/j.kint.2015.12.003_bib5","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1056\/NEJM200104123441506","article-title":"Complement. Second of two parts","volume":"344","author":"Walport","year":"2001","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.kint.2015.12.003_bib6","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/S0952-7915(98)80031-9","article-title":"The mannose receptor is a pattern recognition receptor involved in host defense","volume":"10","author":"Stahl","year":"1998","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.kint.2015.12.003_bib7","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1146\/annurev-immunol-030409-101250","article-title":"Properdin: emerging roles of a pattern-recognition molecule","volume":"28","author":"Kemper","year":"2010","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.kint.2015.12.003_bib8","doi-asserted-by":"crossref","first-page":"4685","DOI":"10.1073\/pnas.1219260110","article-title":"Dimerization of complement factor H-related proteins modulates complement activation in\u00a0vivo","volume":"110","author":"Goicoechea de Jorge","year":"2013","journal-title":"Proc Natl Acad U S A"},{"key":"10.1016\/j.kint.2015.12.003_bib9","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.molimm.2013.06.001","article-title":"Complement factor H related proteins (CFHRs)","volume":"56","author":"Skerka","year":"2013","journal-title":"Mol Immunol"},{"key":"10.1016\/j.kint.2015.12.003_bib10","doi-asserted-by":"crossref","first-page":"3733","DOI":"10.1182\/blood-2013-12-547067","article-title":"Biomarkers of terminal complement activation confirm the diagnosis of aHUS and differentiate aHUS from TTP","volume":"123","author":"Cataland","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.kint.2015.12.003_bib11","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1111\/j.1365-2141.2012.09168.x","article-title":"The use of 'real-time' complement analysis to differentiate atypical haemolytic uraemic syndrome from other forms of thrombotic microangiopathies","volume":"158","author":"Prohaszka","year":"2012","journal-title":"Br J Haematol"},{"key":"10.1016\/j.kint.2015.12.003_bib12","first-page":"895","article-title":"SLICC Revision of the ACR Classification Criteria for SLE","volume":"60","author":"Petri","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.kint.2015.12.003_bib13","first-page":"201568","article-title":"Blockade of alternative complement pathway in dense deposit disease","volume":"2014","author":"Berthe-Aucejo","year":"2014","journal-title":"Case Rep Nephrol"},{"key":"10.1016\/j.kint.2015.12.003_bib14","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1182\/blood-2014-02-558296","article-title":"Dynamics of complement activation in aHUS and how to monitor eculizumab therapy","volume":"124","author":"Noris","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.kint.2015.12.003_bib15","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1093\/clinchem\/32.2.275","article-title":"Homogeneous, liposome-based assay for total complement activity in serum","volume":"32","author":"Bowden","year":"1986","journal-title":"Clin Chem"},{"key":"10.1016\/j.kint.2015.12.003_bib16","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1093\/clinchem\/41.4.586","article-title":"Automated homogeneous liposome-based assay system for total complement activity","volume":"41","author":"Yamamoto","year":"1995","journal-title":"Clin Chem"},{"key":"10.1016\/j.kint.2015.12.003_bib17","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1053\/j.ajkd.2014.10.023","article-title":"C3 glomerulonephritis associated with complement factor B mutation","volume":"65","author":"Sethi","year":"2015","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.kint.2015.12.003_bib18","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1681\/ASN.2010080795","article-title":"Allelic variants of complement genes associated with dense deposit disease","volume":"22","author":"Abrera-Abeleda","year":"2011","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2015.12.003_bib19","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.molimm.2014.06.030","article-title":"Are complement deficiencies really rare? Overview on prevalence, clinical importance and modern diagnostic approach","volume":"61","author":"Grumach","year":"2014","journal-title":"Mol Immunol"},{"key":"10.1016\/j.kint.2015.12.003_bib20","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.molimm.2004.01.003","article-title":"Functional analysis in serum from atypical hemolytic uremic syndrome patients reveals impaired protection of host cells associated with mutations in factor H","volume":"41","author":"Sanchez-Corral","year":"2004","journal-title":"Mol Immunol"},{"key":"10.1016\/j.kint.2015.12.003_bib21","doi-asserted-by":"crossref","first-page":"5307","DOI":"10.1182\/blood-2007-08-106153","article-title":"Factor H dysfunction in patients with atypical hemolytic uremic syndrome contributes to complement deposition on platelets and their activation","volume":"111","author":"Stahl","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.kint.2015.12.003_bib22","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1182\/blood-2007-02-071472","article-title":"Anti factor H autoantibodies block C-terminal recognition function of factor H in hemolytic uremic syndrome","volume":"110","author":"Jozsi","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.kint.2015.12.003_bib23","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1016\/j.molimm.2009.12.001","article-title":"Impact of compound heterozygous complement factor H mutations on development of atypical hemolytic uremic syndrome: a pedigree revisited","volume":"47","author":"Johnson","year":"2010","journal-title":"Mol Immunol"},{"key":"10.1016\/j.kint.2015.12.003_bib24","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1038\/ki.2012.63","article-title":"Acquired and genetic complement abnormalities play a critical role in dense deposit disease and other C3 glomerulopathies","volume":"82","author":"Servais","year":"2012","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2015.12.003_bib25","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/ki.2012.384","article-title":"Atypical postinfectious glomerulonephritis is associated with abnormalities in the alternative pathway of complement","volume":"83","author":"Sethi","year":"2013","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2015.12.003_bib26","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/ki.2012.212","article-title":"C3 glomerulonephritis: clinicopathological findings, complement abnormalities, glomerular proteomic profile, treatment, and follow-up","volume":"82","author":"Sethi","year":"2012","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2015.12.003_bib27","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1182\/blood-2005-10-007252","article-title":"Genetics of HUS: the impact of MCP, CFH, and IF mutations on clinical presentation, response to treatment, and outcome","volume":"108","author":"Caprioli","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.kint.2015.12.003_bib28","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.2215\/CJN.02210310","article-title":"Relative role of genetic complement abnormalities in sporadic and familial aHUS and their impact on clinical phenotype","volume":"5","author":"Noris","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2015.12.003_bib29","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1007\/s00467-012-2131-y","article-title":"Atypical hemolytic uremic syndrome in children: complement mutations and clinical characteristics","volume":"27","author":"Geerdink","year":"2012","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.kint.2015.12.003_bib30","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1681\/ASN.2012090884","article-title":"Combined complement gene mutations in atypical hemolytic uremic syndrome influence clinical phenotype","volume":"24","author":"Bresin","year":"2013","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2015.12.003_bib31","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1159\/000187063","article-title":"Hypocomplementemia and leukocytosis in diarrhea-associated hemolytic uremic syndrome","volume":"62","author":"Robson","year":"1992","journal-title":"Nephron"},{"key":"10.1016\/j.kint.2015.12.003_bib32","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1056\/NEJMc1100859","article-title":"Eculizumab in severe Shiga-toxin-associated HUS","volume":"364","author":"Lapeyraque","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.kint.2015.12.003_bib33","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1160\/TH04-07-0450","article-title":"Complement activation: the missing link between ADAMTS-13 deficiency and microvascular thrombosis of thrombotic microangiopathies","volume":"93","author":"Ruiz-Torres","year":"2005","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.kint.2015.12.003_bib34","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/j.1365-3083.2006.01729.x","article-title":"Clinical aspects and molecular basis of primary deficiencies of complement component C3 and its regulatory proteins factor I and factor H","volume":"63","author":"Reis","year":"2006","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.kint.2015.12.003_bib35","doi-asserted-by":"crossref","first-page":"3838","DOI":"10.1016\/j.molimm.2007.06.150","article-title":"Complement analysis in the 21st century","volume":"44","author":"Mollnes","year":"2007","journal-title":"Mol Immunol"},{"key":"10.1016\/j.kint.2015.12.003_bib36","doi-asserted-by":"crossref","first-page":"2803","DOI":"10.4049\/jimmunol.173.4.2803","article-title":"Complete complement components C4A and C4B deficiencies in human kidney diseases and systemic lupus erythematosus","volume":"173","author":"Yang","year":"2004","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.kint.2015.12.003_bib37","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0022-1759(00)00251-9","article-title":"Long PCR detection of the\u00a0C4A null allele in B8-C4AQ0-C4B1-DR3","volume":"244","author":"Grant","year":"2000","journal-title":"J\u00a0Immunol Methods"},{"key":"10.1016\/j.kint.2015.12.003_bib38","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.2215\/CJN.01820214","article-title":"Defining the complement biomarker profile of C3 glomerulopathy","volume":"9","author":"Zhang","year":"2014","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2015.12.003_bib39","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1006\/clim.2000.4878","article-title":"Deficiency of human complement factor I associated with lowered factor H","volume":"96","author":"Naked","year":"2000","journal-title":"Clin Immunol"},{"key":"10.1016\/j.kint.2015.12.003_bib40","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.molimm.2006.07.004","article-title":"Implications of the initial mutations in membrane cofactor protein (MCP; CD46) leading to atypical hemolytic uremic syndrome","volume":"44","author":"Richards","year":"2007","journal-title":"Mol Immunol"},{"key":"10.1016\/j.kint.2015.12.003_bib41","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1681\/ASN.2005101051","article-title":"Genetic and functional analyses of membrane cofactor protein (CD46) mutations in atypical hemolytic uremic syndrome","volume":"17","author":"Fremeaux-Bacchi","year":"2006","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2015.12.003_bib42","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/j.1423-0410.2011.01522.x","article-title":"Complement activation products in liquid stored plasma and C3a kinetics after transfusion of autologous plasma","volume":"102","author":"Norda","year":"2012","journal-title":"Vox Sang"},{"key":"10.1016\/j.kint.2015.12.003_bib43","first-page":"63","article-title":"Acute complement activation during an anaphylactoid reaction to blood transfusion and the disappearance rate of C3c and C3d from the circulation","volume":"12","author":"Teisner","year":"1983","journal-title":"J\u00a0Clin Lab Immunol"},{"key":"10.1016\/j.kint.2015.12.003_bib44","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1128\/CVI.00486-06","article-title":"Use of serum or buffer-changed EDTA-plasma in a rapid, inexpensive, and easy-to-perform hemolytic complement assay for differential diagnosis of systemic lupus erythematosus and monitoring of patients with the disease","volume":"14","author":"Ekdahl","year":"2007","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.kint.2015.12.003_bib45","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1002\/art.1780390716","article-title":"Sensitivity and specificity of plasma and urine complement split products as indicators of lupus disease activity","volume":"39","author":"Manzi","year":"1996","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.kint.2015.12.003_bib46","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1111\/jth.12369","article-title":"Complement activation and mortality during an acute episode of thrombotic thrombocytopenic purpura","volume":"11","author":"Wu","year":"2013","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.kint.2015.12.003_bib47","doi-asserted-by":"crossref","first-page":"265","DOI":"10.2215\/CJN.07900811","article-title":"Causes of alternative pathway dysregulation in dense deposit disease","volume":"7","author":"Zhang","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2015.12.003_bib48","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1053\/j.ajkd.2015.02.326","article-title":"Soluble C5b-9 as a biomarker for complement activation in atypical hemolytic uremic syndrome","volume":"65","author":"Bu","year":"2015","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.kint.2015.12.003_bib49","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1111\/j.1538-7836.2012.04674.x","article-title":"Complement activation in thrombotic thrombocytopenic purpura","volume":"10","author":"Reti","year":"2012","journal-title":"J\u00a0Thromb Haemost"},{"issue":"116","key":"10.1016\/j.kint.2015.12.003_bib50","doi-asserted-by":"crossref","first-page":"4060","DOI":"10.1182\/blood-2010-07-271445","article-title":"How I treat patients with thrombotic thrombocytopenic purpura: 2010","author":"George","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.kint.2015.12.003_bib51","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1182\/blood-2005-03-1087","article-title":"Severe secondary deficiency of von Willebrand factor-cleaving protease (ADAMTS13) in patients with sepsis-induced disseminated intravascular coagulation: its correlation with development of renal failure","volume":"107","author":"Ono","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.kint.2015.12.003_bib52","doi-asserted-by":"crossref","first-page":"121","DOI":"10.3324\/haematol.10262","article-title":"Acquired ADAMTS-13 deficiency in pediatric patients with severe sepsis","volume":"92","author":"Nguyen","year":"2007","journal-title":"Haematologica"},{"key":"10.1016\/j.kint.2015.12.003_bib53","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1160\/TH08-01-0006","article-title":"Comprehensive analysis of ADAMTS13 in patients with liver cirrhosis","volume":"99","author":"Uemura","year":"2008","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.kint.2015.12.003_bib54","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1160\/TH03-11-0683","article-title":"von Willebrand factor-cleaving protease (ADAMTS13) activity in normal non-pregnant women, pregnant and post-delivery women","volume":"92","author":"Sanchez-Luceros","year":"2004","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.kint.2015.12.003_bib55","doi-asserted-by":"crossref","first-page":"2730","DOI":"10.1182\/blood.V98.9.2730","article-title":"Changes in health and disease of the metalloprotease that cleaves von Willebrand factor","volume":"98","author":"Mannucci","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.kint.2015.12.003_bib56","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1182\/blood-2013-03-492421","article-title":"Partial ADAMTS13 deficiency in atypical hemolytic uremic syndrome","volume":"122","author":"Feng","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.kint.2015.12.003_bib57","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1016\/j.molimm.2010.02.002","article-title":"Anti-factor B autoantibody in dense deposit disease","volume":"47","author":"Strobel","year":"2010","journal-title":"Mol Immunol"},{"key":"10.1016\/j.kint.2015.12.003_bib58","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/j.1365-2796.1997.tb00018.x","article-title":"Hypocomplementaemia caused by C3 nephritic factors (C3 NeF): clinical findings and the coincidence of\u00a0C3 NeF type II with anti-C1q autoantibodies","volume":"242","author":"Skattum","year":"1997","journal-title":"J\u00a0Intern Med"},{"key":"10.1016\/j.kint.2015.12.003_bib59","doi-asserted-by":"crossref","first-page":"748","DOI":"10.2215\/CJN.12901211","article-title":"Eculizumab for dense deposit disease and C3 glomerulonephritis","volume":"7","author":"Bomback","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2015.12.003_bib60","first-page":"1747","article-title":"Hypocomplementaemia of poststreptococcal acute glomerulonephritis is associated with C3 nephritic factor (C3NeF) IgG autoantibody activity","volume":"9","author":"Fremeaux-Bacchi","year":"1994","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.kint.2015.12.003_bib61","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/S0140-6736(72)91740-0","article-title":"C3 breakdown by serum from patients with acute post-streptococcal nephritis","volume":"2","author":"Williams","year":"1972","journal-title":"Lancet"},{"key":"10.1016\/j.kint.2015.12.003_bib62","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/sj.ki.5000269","article-title":"Deletion of Lys224 in regulatory domain 4 of Factor H reveals a novel pathomechanism for dense deposit disease (MPGN II)","volume":"70","author":"Licht","year":"2006","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2015.12.003_bib63","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/0090-1229(90)90018-L","article-title":"Production of IgG and IgM autoantibody to the alternative pathway C3 convertase in normal individuals and patients with membranoproliferative glomerulonephritis","volume":"57","author":"Spitzer","year":"1990","journal-title":"Clin Immunol Immunopathol"},{"key":"10.1016\/j.kint.2015.12.003_bib64","first-page":"253","article-title":"C3 nephritic factor and hypocomplementaemia in a clinically healthy individual","volume":"54","author":"Gewurz","year":"1983","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.kint.2015.12.003_bib65","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/BF03029146","article-title":"Selective C3 deficiency due to C3 nephritic factor in an apparently healthy girl","volume":"15","author":"Tedesco","year":"1985","journal-title":"Ric Clin Lab"},{"key":"10.1016\/j.kint.2015.12.003_bib66","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1136\/bmj.1.6008.501-a","article-title":"C3 activator and hypocomplementaemia in a \u201chealthy\u201d woman","volume":"1","author":"Karstorp","year":"1976","journal-title":"Br Med J"},{"key":"10.1016\/j.kint.2015.12.003_bib67","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1172\/JCI109787","article-title":"Nephritic factor of the classical pathway of complement: immunoglobulin G autoantibody directed against the classical pathway C3 convetase enzyme","volume":"65","author":"Halbwachs","year":"1980","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.kint.2015.12.003_bib68","first-page":"417","article-title":"Stabilization of the classical pathway C3 convertase C42, by a factor F-42, isolated from serum of patients with systemic lupus erythematosus","volume":"40","author":"Daha","year":"1980","journal-title":"Immunology"},{"key":"10.1016\/j.kint.2015.12.003_bib69","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.clim.2012.09.007","article-title":"Autoantibody stabilization of the classical pathway C3 convertase leading to C3 deficiency and Neisserial sepsis: C4 nephritic factor revisited","volume":"145","author":"Miller","year":"2012","journal-title":"Clin Immunol"},{"key":"10.1016\/j.kint.2015.12.003_bib70","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1111\/j.1365-2249.1994.tb06530.x","article-title":"Occurrence of C3 nephritic factor and C4 nephritic factor in membranoproliferative glomerulonephritis (MPGN)","volume":"95","author":"Ohi","year":"1994","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.kint.2015.12.003_bib71","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.imbio.2013.06.004","article-title":"Standardisation of the factor H autoantibody assay","volume":"219","author":"Watson","year":"2014","journal-title":"Immunobiology"},{"key":"10.1016\/j.kint.2015.12.003_bib72","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1681\/ASN.2004050380","article-title":"Anti-Factor H autoantibodies associated with atypical hemolytic uremic syndrome","volume":"16","author":"Dragon-Durey","year":"2005","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2015.12.003_bib73","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1016\/j.molimm.2011.04.005","article-title":"Dense deposit disease","volume":"48","author":"Smith","year":"2011","journal-title":"Mol Immunol"},{"key":"10.1016\/j.kint.2015.12.003_bib74","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.2215\/CJN.07110810","article-title":"Proliferative glomerulonephritis secondary to dysfunction of the alternative pathway of complement","volume":"6","author":"Sethi","year":"2011","journal-title":"Clin\u00a0J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2015.12.003_bib75","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1084\/jem.175.4.939","article-title":"Activation of the alternative pathway of complement by monoclonal lambda light chains in membranoproliferative glomerulonephritis","volume":"175","author":"Meri","year":"1992","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.kint.2015.12.003_bib76","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.2215\/CJN.06180710","article-title":"Glomerulonephritis with isolated C3 deposits and monoclonal gammopathy: a fortuitous association?","volume":"6","author":"Bridoux","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2015.12.003_bib77","doi-asserted-by":"crossref","first-page":"770","DOI":"10.2215\/CJN.06760909","article-title":"Membranoproliferative glomerulonephritis secondary to monoclonal gammopathy","volume":"5","author":"Sethi","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2015.12.003_bib78","unstructured":"Bu F, Ghiringhelli Borsa N, Jones M, et\u00a0al. High-throughput genetic testing for the thrombotic microangiopathies and C3 glomerulopathies. J Am Soc Nephrol, in press."},{"key":"10.1016\/j.kint.2015.12.003_bib79","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1681\/ASN.2013050453","article-title":"Comprehensive genetic analysis of complement and coagulation genes in atypical hemolytic uremic syndrome","volume":"25","author":"Bu","year":"2014","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2015.12.003_bib80","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/nrneph.2014.250","article-title":"Podocyte dysfunction in atypical haemolytic uraemic syndrome","volume":"11","author":"Noris","year":"2015","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.kint.2015.12.003_bib81","doi-asserted-by":"crossref","unstructured":"Barbour TD, Ruseva MM, Pickering MC. Update on C3 glomerulopathy [e-pub ahead of print]. Nephrol Dial Transplant. http:\/\/dx.doi.org\/10.1093\/ndt\/gfu317.","DOI":"10.1093\/ndt\/gfu317"},{"key":"10.1016\/j.kint.2015.12.003_bib82","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/ki.2011.291","article-title":"Complement factor H variants I890 and L1007 while commonly associated with atypical hemolytic uremic syndrome are polymorphisms with no functional significance","volume":"81","author":"Tortajada","year":"2012","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2015.12.003_bib83","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1186\/1471-2105-15-114","article-title":"Biological relevance of CNV calling methods using familial relatedness including monozygotic twins","volume":"15","author":"Castellani","year":"2014","journal-title":"BMC Bioinformatics"},{"key":"10.1016\/j.kint.2015.12.003_bib84","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1002\/humu.21445","article-title":"Performance of mutation pathogenicity prediction methods on missense variants","volume":"32","author":"Thusberg","year":"2011","journal-title":"Hum Mutat"},{"key":"10.1016\/j.kint.2015.12.003_bib85","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med"},{"key":"10.1016\/j.kint.2015.12.003_bib86","doi-asserted-by":"crossref","first-page":"8761","DOI":"10.1073\/pnas.1019338108","article-title":"Common polymorphisms in C3, factor B, and factor H collaborate to determine systemic complement activity and disease risk","volume":"108","author":"Heurich","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.kint.2015.12.003_bib87","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1055\/s-0034-1375701","article-title":"Pathology of renal diseases associated with dysfunction of the alternative pathway of complement: C3 glomerulopathy and atypical hemolytic uremic syndrome (aHUS)","volume":"40","author":"Sethi","year":"2014","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.kint.2015.12.003_bib88","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1038\/ki.2013.377","article-title":"C3 glomerulopathy: consensus report","volume":"84","author":"Pickering","year":"2013","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2015.12.003_bib89","doi-asserted-by":"crossref","first-page":"2852","DOI":"10.1681\/ASN.2014040406","article-title":"C4d as a diagnostic tool in the diagnosis of proliferative glomerulonephritis","volume":"26","author":"Sethi","year":"2015","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2015.12.003_bib90","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1038\/ki.2008.657","article-title":"Glomeruli of dense deposit disease contain components of the alternative and terminal complement pathway","volume":"75","author":"Sethi","year":"2009","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2015.12.003_bib91","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1111\/ajt.12297","article-title":"Two patients with history of STEC-HUS, posttransplant recurrence and complement gene mutations","volume":"13","author":"Alberti","year":"2013","journal-title":"Am J Transplant"},{"key":"10.1016\/j.kint.2015.12.003_bib92","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1067\/mpd.2001.112649","article-title":"Familial hemolytic uremic syndrome associated with complement factor H deficiency","volume":"138","author":"Landau","year":"2001","journal-title":"J\u00a0Pediatr"}],"container-title":["Kidney International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S008525381500071X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S008525381500071X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,6,2]],"date-time":"2022-06-02T04:38:41Z","timestamp":1654144721000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S008525381500071X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2]]},"references-count":92,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,2]]}},"alternative-id":["S008525381500071X"],"URL":"https:\/\/doi.org\/10.1016\/j.kint.2015.12.003","relation":{},"ISSN":["0085-2538"],"issn-type":[{"value":"0085-2538","type":"print"}],"subject":[],"published":{"date-parts":[[2016,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diagnosis of complement alternative pathway disorders","name":"articletitle","label":"Article Title"},{"value":"Kidney International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.kint.2015.12.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 International Society of Nephrology. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}